Home> Products> single oral dose

{ "products": [ { "_id": "69c3af3e5b76c936a0276e2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lobeglitazone Sulfate 0.5 mg", "description": "LOBEGLITONE 0.5 is an advanced oral anti-diabetic medication containing Lobeglitazone Sulfate 0.5 mg, developed for the effective management of Type 2 Diabetes Mellitus. In today’s fast-paced lifestyle, diabetes has become a widespread metabolic disorder that requires long-term control to prevent serious complications. LOBEGLITONE 0.5 is designed to improve insulin sensitivity and help maintain optimal blood glucose levels in adults.\n\nBelonging to the thiazolidinedione (TZD) class of drugs, Lobeglitazone works at the cellular level to enhance the body’s response to insulin. It is particularly beneficial for patients who struggle with insulin resistance, a key factor in Type 2 diabetes. With its potent action and improved safety profile, LOBEGLITONE 0.5 offers a reliable option for modern diabetes care.\n\nComposition Overview\n\nEach tablet of LOBEGLITONE 0.5 contains:\n\nLobeglitazone Sulfate equivalent to Lobeglitazone 0.5 mg\n\nThis low-dose yet highly effective formulation ensures better glycemic control with minimal risk when used appropriately under medical supervision.\n\nHow It Works\n\nLOBEGLITONE 0.5 works by targeting insulin resistance, one of the main causes of Type 2 diabetes. It activates PPAR-γ (Peroxisome Proliferator-Activated Receptor Gamma) receptors found in fat cells, muscle tissue, and the liver.\n\nThrough this mechanism:\n\nThe body becomes more sensitive to insulin\nGlucose uptake by cells increases\nExcess glucose production in the liver decreases\n\nAs a result, blood sugar levels are effectively controlled without directly increasing insulin secretion, reducing the risk of sudden hypoglycemia.\n\nUses of LOBEGLITONE 0.5\n1. Management of Type 2 Diabetes Mellitus\n\nLOBEGLITONE 0.5 is primarily used to control blood glucose levels in adults with Type 2 diabetes, especially in cases where insulin resistance is significant.\n\n2. Combination Therapy\n\nIt can be used along with other anti-diabetic medications such as:\n\nMetformin\nSulfonylureas\nDPP-4 inhibitors\n\nThis combination approach helps achieve better glycemic control when a single drug is not sufficient.\n\n3. Long-Term Diabetes Control\n\nHelps reduce the risk of long-term complications such as nerve damage, kidney disease, and cardiovascular issues when used consistently.\n\nKey Benefits\n✔ Improves Insulin Sensitivity\n\nEnhances the body’s natural ability to use insulin effectively, addressing the root cause of Type 2 diabetes.\n\n✔ Stable Blood Sugar Control\n\nProvides consistent glycemic control without sudden spikes or drops.\n\n✔ Low Risk of Hypoglycemia\n\nSince it does not stimulate insulin secretion directly, the risk of low blood sugar is minimal.\n\n✔ Supports Lipid Profile\n\nMay help improve cholesterol levels by reducing triglycerides and increasing good HDL cholesterol.\n\n✔ Once-Daily Convenience\n\nSimple dosing improves patient compliance and ease of long-term use.\n\n✔ Effective in Resistant Cases\n\nIdeal for patients who do not respond adequately to first-line therapies.\n\nDirections for Use\nTake LOBEGLITONE 0.5 exactly as prescribed by your healthcare provider.\nUsually taken once daily, with or without food.\nSwallow the tablet whole with water.\nMaintain a balanced diet and regular exercise routine for best results.\n\nImportant: Do not stop or change the dosage without consulting your doctor.\n\nPossible Side Effects\n\nLOBEGLITONE 0.5 is generally well tolerated, but some individuals may experience side effects.\n\nCommon Side Effects\nWeight gain\nMild swelling (edema)\nHeadache\nMuscle pain\nLess Common Side Effects\nUpper respiratory tract infections\nFatigue\nIncreased appetite\nRare but Serious Side Effects\nFluid retention leading to heart-related issues\nLiver function abnormalities\nBone fractures (with long-term use in some patients)\n\nIf any severe or persistent symptoms occur, immediate medical attention is advised.\n\nPrecautions\nNot recommended for patients with severe heart failure.\nUse cautiously in individuals with liver disorders.\nRegular monitoring of blood glucose and liver function is essential.\nInform your doctor about any existing medical conditions or medications.\nPregnant and breastfeeding women should use only if prescribed.\nStorage Instructions\nStore in a cool and dry place below 25°C\nKeep away from moisture and direct sunlight\nKeep out of reach of children\nLifestyle Recommendations\n\nFor optimal results with LOBEGLITONE 0.5, patients should:\n\nFollow a diabetic-friendly diet\nEngage in regular physical activity\nMonitor blood sugar levels consistently\nAvoid smoking and limit alcohol intake\n\nThese lifestyle modifications enhance the effectiveness of the medication and promote overall health.\n\nConclusion\n\nLOBEGLITONE 0.5 (Lobeglitazone Sulfate 0.5 mg) represents a modern and effective solution for managing Type 2 diabetes, particularly in patients with insulin resistance. Its targeted mechanism, combined with a favorable safety profile, makes it a valuable addition to diabetes treatment regimens.", "price": 86.0, "discountamount": 60.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2353, "imageuri": "https://productimages.withfloats.com/actual/69c3af403b4966c256447629.png", "tileimageuri": "https://productimages.withfloats.com/tile/69c3af403b4966c256447629.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-25T09:47:42.831Z", "updatedon": "2026-03-25T09:47:42.831Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lobeglitazone-sulfate-0-5-mg/2353", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LOBEGLITONE 0.5", "category": "DIABETIC RANGE", "tags": [ "lobeglitazone sulfate 0.5 mg tablet uses", "lobeglitazone 0.5 mg for type 2 diabetes treatment", "lobeglitazone sulfate dosage and benefits", "lobeglitazone tablet for blood sugar management", "lobeglitazone 0.5 mg daily dose effectiveness", "lobeglitazone 0.5 mg price in india", "lobeglitazone 0.5 mg price in india", "lobeglitazone sulfate 0.5 mg for insulin resistance in type 2 diabetes india", "lobeglitazone tzds class drug for blood sugar control", "oral lobeglitazone sulfate tablets for diabetes management" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "699990a8814d89cb6a29a9c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ferric carboxymaltose injection", "description": "RUDIX FCM IV is a sterile intravenous iron formulation containing Ferric carboxymaltose, designed for the rapid and effective treatment of iron deficiency and iron deficiency anemia (IDA). It is specifically developed for patients who require fast iron replenishment, cannot tolerate oral iron supplements, or have conditions where oral iron therapy is ineffective.\n\nIron deficiency remains one of the most common nutritional deficiencies worldwide, affecting women, children, patients with chronic diseases, and individuals recovering from surgery. RUDIX FCM IV provides a modern, safe, and convenient approach to restoring iron stores efficiently under medical supervision.\n\nProduct Overview\n\nProduct Name: RUDIX FCM IV\n\nGeneric Name: Ferric Carboxymaltose Injection\n\nDosage Form: Intravenous injection / infusion\n\nRoute of Administration: IV use only\n\nIndication: Treatment of iron deficiency and iron deficiency anemia\n\nRUDIX FCM IV is formulated using advanced iron-carbohydrate complex technology that allows controlled and gradual release of iron into the bloodstream. This reduces the risk of free iron toxicity while ensuring effective replenishment of hemoglobin levels and iron stores.\n\nWhat is Ferric Carboxymaltose?\n\nFerric carboxymaltose is a next-generation intravenous iron complex. Unlike traditional iron salts, it allows the administration of larger single doses in a shorter duration, reducing the need for multiple hospital visits. The iron core is tightly bound within a carbohydrate shell, enabling controlled release and minimizing adverse reactions compared to older IV iron formulations.\n\nOnce administered, iron from ferric carboxymaltose is taken up by the body's iron-binding proteins and transported to the bone marrow, where it supports red blood cell production and improves hemoglobin levels.\n\nUses of RUDIX FCM IV\n\nRUDIX FCM IV is indicated in the following medical conditions:\n\n1. Iron Deficiency Anemia (IDA)\n\nUsed when oral iron therapy is ineffective, poorly tolerated, or when rapid correction of anemia is required.\n\n2. Chronic Kidney Disease (CKD)\n\nPatients with CKD often experience anemia due to reduced erythropoietin production and iron deficiency. IV iron helps restore iron levels efficiently.\n\n3. Postpartum Anemia\n\nWomen who experience significant blood loss during childbirth may require quick iron restoration.\n\n4. Heavy Menstrual Bleeding\n\nFor women with chronic blood loss leading to iron deficiency.\n\n5. Gastrointestinal Disorders\n\nConditions such as inflammatory bowel disease (IBD), celiac disease, or gastric surgery can impair iron absorption, making IV iron therapy necessary.\n\n6. Pre- and Post-Surgical Patients\n\nPatients undergoing major surgeries may require rapid iron replenishment to improve recovery.\n\nKey Benefits of RUDIX FCM IV\n✔ Rapid Iron Replenishment\n\nAllows administration of high doses in a single sitting, helping patients recover faster compared to oral supplements.\n\n✔ Improved Patient Compliance\n\nFewer hospital visits are required due to the ability to deliver larger doses in one infusion.\n\n✔ Better Tolerability\n\nLower incidence of gastrointestinal side effects compared to oral iron therapy.\n\n✔ Controlled Iron Release\n\nThe stable iron-carbohydrate complex reduces the risk of free iron reactions.\n\n✔ Suitable for Multiple Patient Groups\n\nSafe for use in adults with various underlying medical conditions under medical supervision.\n\n✔ Clinically Proven Effectiveness\n\nHelps improve hemoglobin levels, replenish iron stores, and reduce fatigue and weakness associated with anemia.\n\nDosage and Administration\n\nRUDIX FCM IV should be administered only by qualified healthcare professionals in a clinical setting. The dosage depends on:\n\nPatient’s body weight\n\nHemoglobin level\n\nSeverity of iron deficiency\n\nUnderlying medical condition\n\nIt may be given as a slow intravenous injection or diluted in saline for infusion. Monitoring during and after administration is recommended to ensure patient safety.\n\nPossible Side Effects\n\nLike all medications, RUDIX FCM IV may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nHeadache\n\nNausea\n\nDizziness\n\nInjection site reactions\n\nFlushing\n\nLess Common but Serious Reactions:\n\nHypersensitivity reactions\n\nHypotension (low blood pressure)\n\nAllergic reactions\n\nShortness of breath\n\nPatients should be monitored during infusion. Immediate medical attention is required if signs of severe allergic reactions occur.\n\nPrecautions and Warnings\n\nShould not be used in patients with known hypersensitivity to ferric carboxymaltose.\n\nNot recommended in patients with iron overload disorders such as hemochromatosis.\n\nUse cautiously in patients with liver dysfunction.\n\nPregnancy and lactation use should be evaluated by a healthcare provider.\n\nMust be administered in facilities equipped to manage anaphylactic reactions.\n\nStorage Instructions\n\nStore at controlled room temperature.\n\nProtect from light.\n\nDo not freeze.\n\nKeep out of reach of children.\n\nWhy Choose RUDIX FCM IV?\nRUDIX FCM IV stands out due to its high-quality formulation, safety profile, and effectiveness in treating iron deficiency anemia. It offers healthcare providers a reliable option for rapid correction of iron deficiency while minimizing patient inconvenience.\n\nIts ability to deliver higher doses in fewer sessions makes it a preferred choice in hospitals, nephrology clinics, gynecology practices, and surgical recovery units.\nConclusion\nIron deficiency anemia can significantly impact quality of life, causing fatigue, weakness, reduced immunity, and impaired cognitive function. Timely correction is essential to restore overall health and vitality.", "price": 2050.0, "discountamount": 615.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2310, "imageuri": "https://productimages.withfloats.com/actual/699990ae4601efddb00d005a.png", "tileimageuri": "https://productimages.withfloats.com/tile/699990ae4601efddb00d005a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-21T11:02:00.008Z", "updatedon": "2026-05-27T10:36:01.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ferric-carboxymaltose-injection/2310", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RUDIX FCM IV", "category": "GYANECOLOGYRANGE", "tags": [ "ferric carboxymaltose injection 1000mg IV for anemia", "ferric carboxymaltose IV iron therapy dosage guide", "ferric carboxymaltose injection for iron deficiency anemia", "buy ferric carboxymaltose injection online", "ferric carboxymaltose IV injection price per vial", "ferric carboxymaltose injection 50 mg price", "ferric carboxymaltose injection price", "ferric carboxymaltose injection uses in hindi", "ferric carboxymaltose injection uses in hindi", "what is ferric carboxymaltose injection", "what is ferric carboxymaltose injection used for", "Ferric carboxymaltose injection" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "698eccba9206f8f071919fc7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "clobetasol neomycin miconazole cream", "description": "EUROSOFT 4D CREAM represents a sophisticated breakthrough in topical dermatological therapy, combining three powerful active ingredients—clobetasol propionate, neomycin sulfate, and miconazole nitrate—into one comprehensive treatment formulation. This advanced pharmaceutical preparation is specifically designed to address complex skin conditions that involve inflammation, bacterial infection, and fungal colonization simultaneously. The “4D” designation reflects the cream's multidimensional approach to skin healing: it reduces inflammation, eliminates bacterial pathogens, eradicates fungal infections, and promotes overall skin restoration.This prescription-strength cream has been formulated using advanced pharmaceutical technology to ensure optimal penetration, stability, and efficacy. Each gram of EUROSOFT 4D CREAM delivers precise therapeutic doses of its active components, working synergistically to provide rapid relief and comprehensive healing for challenging dermatological conditions that might otherwise require multiple separate medications.Comprehensive Uses and ApplicationsEUROSOFT 4D CREAM is prescribed for a diverse range of dermatological conditions where multiple pathogenic factors contribute to skin disease. The primary indications include infected eczema, where both inflammation and secondary bacterial or fungal infection complicate the condition. Patients suffering from seborrheic dermatitis with secondary infection find significant relief with this triple-action formulation, as it addresses both the inflammatory component and the microbial colonization that often perpetuates this chronic condition.The cream proves particularly valuable in treating intertrigo—inflammatory conditions occurring in skin folds—where moisture, friction, and warmth create an ideal environment for both bacterial and fungal proliferation alongside inflammatory responses. Athletes dealing with infected dermatoses, including cases where fungal infections like tinea have become complicated by bacterial superinfection, benefit from the comprehensive coverage this medication provides.Contact dermatitis cases that have developed secondary infections respond well to EUROSOFT 4D CREAM, as the corticosteroid component addresses the allergic or irritant inflammatory response while the antimicrobial agents tackle opportunistic infections. The cream is also employed in managing various forms of infected psoriasis, particularly in intertriginous areas where both inflammation and infection coexist, creating a challenging therapeutic scenario.Medical professionals may prescribe this formulation for other complex dermatological conditions where the simultaneous presence of inflammation, bacterial infection, and fungal colonization requires a multifaceted treatment approach. The convenience of a single application containing all three therapeutic agents significantly improves patient compliance compared to using multiple separate medications.Key Benefits and Therapeutic AdvantagesThe primary advantage of EUROSOFT 4D CREAM lies in its comprehensive, multi-targeted action. The clobetasol propionate component is a super-potent corticosteroid that rapidly suppresses inflammation, reducing redness, swelling, itching, and discomfort. This powerful anti-inflammatory effect provides quick symptomatic relief, often noticeable within the first few applications, dramatically improving patient comfort and quality of life.Neomycin sulfate, a broad-spectrum aminoglycoside antibiotic, effectively eliminates a wide range of gram-positive and gram-negative bacteria commonly responsible for secondary skin infections. By controlling bacterial proliferation, it prevents infection from spreading, reduces the risk of complications, and accelerates the healing process. This antibacterial protection is crucial in preventing the vicious cycle where infection perpetuates inflammation and vice versa.The miconazole nitrate component provides robust antifungal coverage against dermatophytes, yeasts, and other pathogenic fungi that frequently complicate inflammatory skin conditions. Its fungicidal action ensures complete eradication of fungal elements, preventing recurrence and breaking the cycle of persistent infection that can undermine other therapeutic efforts.The synergistic formulation means patients need only one medication rather than juggling multiple creams or ointments, significantly simplifying their treatment regimen. This convenience improves adherence to prescribed therapy, leading to better outcomes. The cream base is designed for optimal absorption and comfortable application, avoiding the greasiness or stickiness that might deter regular use.EUROSOFT 4D CREAM typically produces visible improvements within days, though complete resolution requires completing the full prescribed course. The rapid symptom relief—particularly reduction in itching, pain, and visible inflammation—provides significant psychological and physical comfort to patients struggling with distressing skin conditions. By addressing all three pathological factors simultaneously, the cream prevents the common problem of treating one aspect of the condition while another remains unaddressed and continues causing symptoms.Important Side Effects and PrecautionsWhile EUROSOFT 4D CREAM is highly effective, users should be aware of potential side effects associated with its potent active ingredients. The clobetasol component, being a super-potent corticosteroid, can cause skin thinning (atrophy), stretch marks (striae), telangiectasia (visible blood vessels), and changes in skin pigmentation with prolonged use. These effects are more likely when the cream is used on thin-skinned areas like the face, groin, or underarms, or when applied under occlusive dressings.Systemic absorption of clobetasol, particularly with extensive application or prolonged use, may suppress the hypothalamic-pituitary-adrenal (HPA) axis, potentially affecting the body's natural cortisol production. This is especially concerning in children, whose body surface area to weight ratio makes them more vulnerable to systemic effects. Other corticosteroid-related effects may include acne-like eruptions, perioral dermatitis, delayed wound healing, and increased susceptibility to skin infections if protective immunity is compromised.Neomycin can cause contact sensitization in susceptible individuals, leading to allergic contact dermatitis. This manifests as increased redness, itching, or rash that paradoxically worsens with continued use. Cross-sensitivity with other aminoglycoside antibiotics is possible. Though rare with topical application, systemic absorption of neomycin could theoretically cause ototoxicity or nephrotoxicity, particularly if applied to large surface areas or compromised skin.Miconazole is generally well-tolerated but can occasionally cause local irritation, burning, or allergic reactions. Some users report mild stinging upon initial application, which typically subsides with continued use.Users should avoid applying the cream to the face for extended periods, near the eyes, or on broken skin unless specifically directed by their healthcare provider. The medication should not be used during pregnancy or breastfeeding without medical supervision. Parents should exercise particular caution when using this cream on children, as pediatric patients are more susceptible to systemic corticosteroid effects.If symptoms worsen, if new symptoms develop, or if no improvement occurs after one week of use, patients should consult their healthcare provider promptly. Signs of possible adverse reactions include excessive irritation, severe itching, rash expansion, or signs of spreading infection.ConclusionEUROSOFT 4D CREAM represents an innovative and highly effective solution for complex dermatological conditions requiring simultaneous anti-inflammatory, antibacterial, and antifungal therapy. Its triple-action formulation addresses the multifaceted nature of infected inflammatory skin diseases, providing comprehensive treatment in a single convenient application. The synergistic combination of clobetasol propionate, neomycin sulfate, and miconazole nitrate delivers rapid symptom relief while promoting complete healing.", "price": 91.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2302, "imageuri": "https://productimages.withfloats.com/actual/698eccbd3d2f9770ce0bdd1c.png", "tileimageuri": "https://productimages.withfloats.com/tile/698eccbd3d2f9770ce0bdd1c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-13T07:03:22.253Z", "updatedon": "2026-03-12T08:14:48.969Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//clobetasol-neomycin-miconazole-cream/2302", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EUROSOFT 4D CREAM", "category": "DERMATALOGY", "tags": [ "Clobetasol Neomycin Miconazole cream", "Clobetasol combination antifungal cream", "Clobetasol Neomycin Miconazole Chlorhexidine cream", "Triple action steroid antibiotic antifungal cream", "Miconazole Neomycin steroid skin cream", "Clobetasol Neomycin antifungal cream 0.5%" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "697df3478c1cd80b2f6e2044", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "flupirtine paracetamol", "description": "FLUREPTIN PCM (Flupirtine + Paracetamol): Powerful Relief from Moderate to Severe Pain\nPain can significantly affect daily life, limiting movement, productivity, and overall well-being. FLUREPTIN PCM, a combination of Flupirtine and Paracetamol, is designed to provide effective and reliable relief from moderate to severe pain while improving patient comfort. This dual-action formulation works on both pain perception and muscle tension, making it a preferred choice for various painful conditions.\n\nProduct Description: What is FLUREPTIN PCM?\n\nFLUREPTIN PCM is a combination analgesic medicine containing Flupirtine, a centrally acting non-opioid pain reliever, and Paracetamol, a widely trusted analgesic and antipyretic agent. Together, these two ingredients offer enhanced pain control compared to single-drug therapy.\n\nFlupirtine works by reducing pain signals in the central nervous system and relaxing tense muscles.\n\nParacetamol helps relieve pain and reduce fever by inhibiting pain-producing chemicals in the body.\n\nThis synergistic combination allows FLUREPTIN PCM to manage pain effectively without causing the gastric irritation commonly associated with NSAIDs.\n\nUses of FLUREPTIN PCM\n\nFLUREPTIN PCM is prescribed for a wide range of painful conditions where strong yet well-tolerated pain relief is required. It is especially useful when pain is associated with muscle tension or nerve involvement.\n\nCommon Uses Include:\n\nMusculoskeletal pain such as back pain, neck pain, and joint pain\n\nPost-operative pain following minor or moderate surgical procedures\n\nOrthopedic pain including sprains, strains, and sports injuries\n\nChronic pain conditions where long-term pain management is needed\n\nTension headaches and migraines\n\nPain due to trauma or injury\n\nFever with body aches, when pain relief and temperature control are both required\n\nFLUREPTIN PCM is often recommended when conventional painkillers alone do not provide adequate relief.\n\nHow FLUREPTIN PCM Works\n\nThe effectiveness of FLUREPTIN PCM lies in its dual mechanism of action:\n\nFlupirtine acts on neuronal potassium channels, stabilizing nerve activity and reducing the transmission of pain signals to the brain. It also has muscle-relaxant properties, which help relieve pain caused by muscle spasms.\n\nParacetamol reduces the production of prostaglandins in the brain, substances responsible for pain and fever.\n\nBy targeting pain through different pathways, FLUREPTIN PCM provides faster and longer-lasting relief.\n\nKey Benefits of FLUREPTIN PCM\n\nFLUREPTIN PCM offers several advantages that make it a reliable option for pain management:\n\n1. Effective Pain Relief\n\nThe combination provides strong relief from moderate to severe pain, especially where muscle tension or nerve pain is involved.\n\n2. Muscle Relaxation\n\nFlupirtine helps relax tight muscles, reducing stiffness and improving mobility.\n\n3. Gentle on the Stomach\n\nUnlike many NSAIDs, FLUREPTIN PCM has a lower risk of causing gastric irritation, making it suitable for patients with sensitive stomachs when used as prescribed.\n\n4. Dual Action Formula\n\nParacetamol enhances the pain-relieving effect while also helping to reduce fever and body aches.\n\n5. Improves Quality of Life\n\nBy controlling pain effectively, FLUREPTIN PCM helps patients return to daily activities with greater comfort.\n\n6. Suitable for Short-Term and Select Long-Term Use\n\nWhen taken under medical supervision, it can be used for acute pain and certain chronic pain conditions.\n\nDosage and Administration\n\nThe dosage of FLUREPTIN PCM should always be followed as advised by a healthcare professional. It is usually taken orally with water and may be taken with or without food, depending on patient tolerance.\n\nDo not exceed the prescribed dose\n\nAvoid prolonged use without medical advice\n\nPatients with liver conditions should use it only under strict supervision\n\nPossible Side Effects of FLUREPTIN PCM\n\nLike all medicines, FLUREPTIN PCM may cause side effects in some individuals, though not everyone experiences them.\n\nCommon Side Effects:\n\nDizziness or drowsiness\n\nMild nausea or stomach discomfort\n\nFatigue or weakness\n\nDry mouth\n\nLess Common but Serious Side Effects:\n\nElevated liver enzymes with prolonged use\n\nAllergic reactions such as rash or itching\n\nYellowing of skin or eyes (indicating liver issues)\n\nIf any unusual or severe symptoms occur, medical attention should be sought immediately.\n\nPrecautions and Warnings\n\nNot recommended for patients with severe liver disease\n\nAvoid alcohol consumption during treatment, as it may increase the risk of liver damage\n\nUse with caution in elderly patients\n\nNot advised during pregnancy or breastfeeding unless prescribed by a doctor\n\nAlways inform your healthcare provider about other medicines you are taking to avoid potential interactions.\nConclusion\nFLUREPTIN PCM (Flupirtine + Paracetamol) is a well-balanced and effective solution for managing moderate to severe pain. Its dual-action formula not only relieves pain but also helps reduce muscle tension and improve mobility. With proper medical guidance, FLUREPTIN PCM can significantly enhance comfort, speed recovery, and improve overall quality of life for patients suffering from painful conditions.", "price": 138.0, "discountamount": 41.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2290, "imageuri": "https://productimages.withfloats.com/actual/697df353fc3cf1d1834163c1.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/697df353fc3cf1d1834163c1.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-31T12:19:19.234Z", "updatedon": "2026-04-04T08:59:21.716Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//flupirtine-paracetamol/2290", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLUREPTIN PCM", "category": "ORTHOLOGYRANG", "tags": [ "flupirtine paracetamol tablets uses", "flupirtine paracetamol combination medicine", "flupirtine paracetamol dosage", "flupirtine paracetamol for pain relief", "flupirtine paracetamol uses in india", "flupirtine paracetamol for back pain", "flupirtine paracetamol nerve pain", "flupirtine paracetamol tablet price in india", "flupirtine paracetamol tablets for chronic pain", "what is flupirtine paracetamol used for", "how flupirtine paracetamol works", "is flupirtine paracetamol safe", "buy flupirtine paracetamol tablets online", "best flupirtine paracetamol tablet brand", "flupirtine paracetamol tablets manufacturer india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6961f2c52800555f6696ac8f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate 100 mg", "description": "GLISITAPTIN 100 is a pharmaceutical formulation containing Sitagliptin Phosphate 100 mg as its active ingredient. This medication represents a significant advancement in the management of type 2 diabetes mellitus, offering patients an effective oral treatment option that works through an innovative mechanism of action. As part of the DPP-4 inhibitor class of antidiabetic medications, GLISITAPTIN 100 has emerged as a trusted choice for healthcare providers and patients seeking reliable glycemic control with a favorable safety profile.\nThe brand name GLISITAPTIN 100 signifies quality, efficacy, and a commitment to helping individuals with type 2 diabetes achieve better health outcomes. Each tablet is precisely formulated to deliver the optimal therapeutic dose of sitagliptin phosphate, ensuring consistent and predictable results in blood sugar management.\nUnderstanding Sitagliptin Phosphate\nSitagliptin phosphate is a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor that has revolutionized diabetes treatment since its introduction. Unlike older diabetes medications that work through insulin secretion or glucose absorption mechanisms alone, sitagliptin operates through the incretin system—a natural bodily process that regulates blood glucose levels in response to food intake.\nThe 100 mg strength available in GLISITAPTIN 100 represents the standard therapeutic dose for most adult patients, providing optimal efficacy while maintaining an excellent safety margin. This once-daily formulation simplifies treatment regimens and promotes better adherence, which is crucial for long-term diabetes management success.\nHow GLISITAPTIN 100 Works\nGLISITAPTIN 100 works through a sophisticated yet elegant mechanism that harnesses your body's natural glucose regulation system. When you eat, your intestines release hormones called incretins, specifically GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These incretins have multiple beneficial effects: they stimulate insulin secretion from the pancreas, suppress glucagon release (which reduces glucose production by the liver), and slow gastric emptying.\nHowever, these beneficial incretins are rapidly broken down by an enzyme called DPP-4, limiting their glucose-lowering effects. GLISITAPTIN 100 inhibits this DPP-4 enzyme, allowing incretins to remain active in your bloodstream for longer periods. This results in better insulin secretion when blood glucose is elevated, reduced glucagon levels, and ultimately improved blood sugar control throughout the day.\nImportantly, because this mechanism is glucose-dependent, GLISITAPTIN 100 primarily works when blood sugar is elevated, which significantly reduces the risk of hypoglycemia (dangerously low blood sugar) compared to some other diabetes medications.\nPrimary Uses and Indications\nType 2 Diabetes Mellitus Management: GLISITAPTIN 100 is primarily indicated for improving glycemic control in adult patients with type 2 diabetes mellitus. It can be prescribed as:\n\nMonotherapy: As a first-line treatment for patients who cannot achieve adequate control through diet and exercise alone, particularly when metformin is contraindicated or not tolerated\nCombination Therapy: Alongside metformin, sulfonylureas, thiazolidinediones, or insulin when these medications alone do not provide sufficient glucose control\nTriple Therapy: In combination with two other antidiabetic agents when dual therapy fails to achieve target HbA1c levels\n\nThe medication is particularly suitable for patients who require effective glucose control but have concerns about weight gain or hypoglycemia, as GLISITAPTIN 100 is weight-neutral and has a low hypoglycemia risk when used as monotherapy.\nKey Benefits of GLISITAPTIN 100\n1. Effective Glycemic Control\nClinical studies have demonstrated that GLISITAPTIN 100 significantly reduces HbA1c levels (a measure of long-term blood sugar control) by approximately 0.5-1.0%, helping patients achieve and maintain target glucose levels. This improvement translates to reduced risk of diabetes-related complications over time.\n2. Low Hypoglycemia Risk\nUnlike sulfonylureas or insulin, GLISITAPTIN 100 has a glucose-dependent mechanism, meaning it primarily works when blood sugar is elevated. This dramatically reduces the risk of hypoglycemic episodes, providing patients with greater safety and peace of mind, especially important for elderly patients or those with unpredictable meal schedules.\n3. Weight Neutral\nGLISITAPTIN 100 does not cause weight gain, a significant advantage over some other diabetes medications like insulin, sulfonylureas, or thiazolidinediones. Maintaining a healthy body weight is crucial for overall diabetes management and cardiovascular health.\n4. Once-Daily Convenience\nThe single daily dose requirement of GLISITAPTIN 100 simplifies treatment regimens, making it easier for patients to maintain adherence. Better adherence directly correlates with improved glycemic control and better long-term outcomes.\n5. Pancreatic Preservation\nBy working through the incretin system, GLISITAPTIN 100 may help preserve pancreatic beta-cell function, potentially slowing the progression of type 2 diabetes. This represents a significant long-term benefit beyond simple glucose control.\n6. Cardiovascular Safety\nClinical trials have demonstrated cardiovascular safety with sitagliptin, an important consideration given that cardiovascular disease is the leading cause of morbidity and mortality in patients with type 2 diabetes.\n7. Renal Dosing Available\nWhile the 100 mg dose is standard, sitagliptin can be adjusted for patients with kidney impairment, making it accessible to a broader patient population, including those with diabetic nephropathy.\n8. Well-Tolerated\nGLISITAPTIN 100 generally has a favorable side effect profile, with most patients experiencing minimal adverse effects, contributing to better quality of life during treatment.\nDosage and Administration\nThe standard recommended dose of GLISITAPTIN 100 is one tablet taken orally once daily, with or without food. The medication can be taken at any time of day, though taking it at the same time daily helps establish a routine and ensures consistent blood levels.\nFor patients with moderate to severe kidney disease, dosage adjustments may be necessary. Your healthcare provider will determine the appropriate dose based on your kidney function tests. It's crucial to follow your doctor's instructions precisely and not adjust your dose without medical guidance.\nPotential Side Effects\nWhile GLISITAPTIN 100 is generally well-tolerated, like all medications, it may cause side effects in some individuals:\nCommon Side Effects (Affecting 1-10% of patients):\n\nUpper respiratory tract infections\nNasopharyngitis (common cold symptoms)\nHeadache\nNausea\nAbdominal pain\nDiarrhea\n\nThese side effects are typically mild and often resolve on their own as your body adjusts to the medication.\nLess Common but Serious Side Effects:\n\nPancreatitis: Severe abdominal pain that may radiate to the back, with or without vomiting, requires immediate medical attention\nSevere Joint Pain: Persistent, severe joint pain has been reported in some patients; inform your doctor if this occurs\nAllergic Reactions: Rare cases of serious allergic reactions including anaphylaxis, angioedema, and severe skin reactions have occurred\nHeart Failure: In patients with existing heart disease, worsening heart failure has been reported\nBullous Pemphigoid: A rare skin condition requiring discontinuation of the medication\n\nWhen Used with Other Diabetes Medications:\nWhen GLISITAPTIN 100 is combined with sulfonylureas or insulin, the risk of hypoglycemia increases. Your doctor may reduce the dose of these medications when adding GLISITAPTIN 100 to your regimen.\nPrecautions and Contraindications\nDo Not Use GLISITAPTIN 100 if:\n\nYou are allergic to sitagliptin or any ingredients in the formulation\nYou have type 1 diabetes or diabetic ketoacidosis\nYou are under 18 years of age (safety and efficacy not established)\n\nUse with Caution if:\n\nYou have a history of pancreatitis\nYou have kidney disease (dose adjustment required)\nYou have heart failure\nYou are pregnant or planning to become pregnant\nYou are breastfeeding\n\nImportant Patient Information\nMonitoring: Regular monitoring of blood glucose levels and HbA1c testing (typically every 3-6 months) is essential to assess treatment effectiveness and make necessary adjustments.\nLifestyle Factors: GLISITAPTIN 100 works best when combined with a healthy diet, regular physical activity, and weight management. Medication alone cannot substitute for comprehensive lifestyle management.\nMissed Dose: If you miss a dose, take it as soon as you remember on the same day. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Never double up doses.\nStorage: Store GLISITAPTIN 100 at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.\nDrug Interactions\nGLISITAPTIN 100 has few significant drug interactions, contributing to its safety profile. However, inform your healthcare provider about all medications, supplements, and herbal products you're taking. Particular attention should be paid to:\n\nOther diabetes medications (may require dose adjustments)\nDigoxin (levels may be slightly increased)\nMedications affecting kidney function\n\nConclusion\nGLISITAPTIN 100 (Sitagliptin Phosphate 100 mg) represents a modern, effective, and well-tolerated option for managing type 2 diabetes mellitus. Its innovative mechanism through the incretin system offers multiple advantages including effective glucose control, low hypoglycemia risk, weight neutrality, and once-daily convenience. These benefits make it an excellent choice for many patients, whether used alone or in combination with other antidiabetic medications.", "price": 464.0, "discountamount": 139.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2272, "imageuri": "https://productimages.withfloats.com/actual/6961f2c8ba33389b8e9f0122.png", "tileimageuri": "https://productimages.withfloats.com/tile/6961f2c8ba33389b8e9f0122.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T06:33:41.727Z", "updatedon": "2026-03-13T05:59:37.431Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-phosphate-100-mg/2272", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN 100", "category": "DIABETIC RANGE", "tags": [ "sitagliptin phosphate 100 mg tablet uses", "sitagliptin phosphate 100 mg dosage", "sitagliptin phosphate 100 mg side effects", "sitagliptin phosphate 100 mg benefits", "sitagliptin phosphate 100 mg price in india", "sitagliptin phosphate tablets 100 mg", "what is sitagliptin phosphate 100 mg used for", "how sitagliptin phosphate works in diabetes", "sitagliptin phosphate 100 mg for type 2 diabetes", "sitagliptin phosphate 100 mg mechanism of action", "sitagliptin phosphate tablet how to take", "medicine to control blood sugar sitagliptin", "tablet for post meal blood sugar control", "sitagliptin phosphate for high blood sugar", "can sitagliptin phosphate cause weight gain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6960c83f3056ad8a5a1aecba", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinnarizine and Domperidone Tablets ", "description": "CLANARIZINE DOM represents an advanced pharmaceutical combination that brings together two potent therapeutic agents—Cinnarizine and Domperidone—in a single convenient tablet formulation. This innovative combination medication addresses multiple aspects of vestibular disorders, motion sickness, and associated nausea and vomiting, providing comprehensive relief for patients suffering from these debilitating conditions. Manufactured under stringent quality control standards, CLANARIZINE DOM offers a synergistic approach to managing symptoms that significantly impact quality of life and daily functioning.The combination of Cinnarizine and Domperidone in CLANARIZINE DOM is based on sound pharmacological principles. While Cinnarizine works primarily on the vestibular system to reduce dizziness and vertigo, Domperidone acts as an effective antiemetic to control nausea and vomiting. Together, these two active ingredients provide more comprehensive symptom control than either agent alone, making CLANARIZINE DOM an excellent choice for patients experiencing vestibular disturbances accompanied by gastrointestinal symptoms.This combination therapy is particularly valuable because vertigo, dizziness, and motion sickness are frequently accompanied by nausea and vomiting. Patients suffering from these conditions often find that addressing only one aspect of their symptoms provides insufficient relief. CLANARIZINE DOM's dual-action formula tackles both the underlying vestibular dysfunction and the accompanying gastrointestinal distress, offering patients a more complete therapeutic solution that improves both comfort and functional capacity.Understanding the Active IngredientsCinnarizine is a calcium channel blocker with specific antihistaminic and vestibular suppressant properties. Unlike systemic calcium channel blockers used for cardiovascular conditions, Cinnarizine selectively acts on the blood vessels in the inner ear and brain, improving blood flow to these areas. This enhanced circulation helps reduce the frequency and severity of vertigo attacks while also preventing motion sickness. Cinnarizine also possesses mild antihistaminic effects that contribute to its anti-nausea properties, though this is not its primary mechanism of action.The medication works by blocking calcium channels in the vestibular system, which helps stabilize the sensory organs responsible for balance. By reducing the excessive stimulation of the vestibular apparatus, Cinnarizine decreases the sensation of spinning or imbalance that characterizes vertigo. Additionally, its vasodilatory effects improve microcirculation in the inner ear, which can be beneficial for conditions where reduced blood flow contributes to symptoms.Domperidone is a peripheral dopamine antagonist that acts primarily as a prokinetic and antiemetic agent. Unlike some antiemetic medications that cross the blood-brain barrier and cause sedation or extrapyramidal side effects, Domperidone works predominantly in the peripheral nervous system. It blocks dopamine receptors in the chemoreceptor trigger zone (CTZ) located outside the blood-brain barrier, effectively preventing nausea and vomiting without causing significant central nervous system effects.Domperidone also enhances gastrointestinal motility by promoting coordinated contractions of the stomach and upper small intestine. This prokinetic effect helps empty the stomach more efficiently, reducing feelings of fullness, bloating, and discomfort that often accompany vestibular disorders. By accelerating gastric emptying, Domperidone also reduces the likelihood of gastroesophageal reflux, which can exacerbate nausea in some patients.The combination of these two medications in CLANARIZINE DOM creates a complementary therapeutic effect. While Cinnarizine addresses the vestibular component of dizziness and vertigo, Domperidone manages the gastrointestinal symptoms that frequently accompany these conditions. This dual approach provides more comprehensive symptom relief and improves overall treatment outcomes compared to monotherapy with either agent alone.Clinical Applications and UsesCLANARIZINE DOM is indicated for a wide range of conditions characterized by vertigo, dizziness, and associated nausea. Understanding these clinical applications helps healthcare providers select appropriate candidates for this combination therapy.Vestibular Disorders: The primary indication for CLANARIZINE DOM includes various vestibular disorders that cause vertigo and imbalance. These conditions include Ménière's disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis. Patients with these disorders experience episodes of spinning sensation, loss of balance, and often severe nausea. CLANARIZINE DOM helps reduce the frequency and intensity of vertigo attacks while controlling the accompanying gastrointestinal symptoms.Motion Sickness: CLANARIZINE DOM is highly effective for preventing and treating motion sickness, whether related to travel by car, boat, airplane, or amusement park rides. The medication can be taken prophylactically before travel or at the onset of symptoms. The combination is particularly useful for individuals who experience severe nausea and vomiting with motion sickness, as Domperidone provides powerful antiemetic effects that complement Cinnarizine's anti-motion-sickness properties.Migraine-Associated Vertigo: Many patients with migraines experience vestibular symptoms, including dizziness, vertigo, and motion sensitivity, either during migraine attacks or as independent episodes. CLANARIZINE DOM can help manage these vestibular manifestations of migraine, reducing both the vertigo and the nausea that often accompany migraine headaches.Post-Concussion Syndrome: Following head injuries, some patients develop persistent dizziness, balance problems, and nausea as part of post-concussion syndrome. CLANARIZINE DOM may provide symptomatic relief for these patients during their recovery period, though it should be used as part of a comprehensive treatment approach that includes rest, gradual return to activities, and vestibular rehabilitation when appropriate.Cerebrovascular Insufficiency: In older adults with reduced blood flow to the brain, symptoms such as dizziness, vertigo, tinnitus (ringing in the ears), and cognitive difficulties may develop. Cinnarizine's vasodilatory properties can improve cerebral circulation, potentially reducing these symptoms. The addition of Domperidone helps manage any associated nausea.Radiation-Induced or Chemotherapy-Induced Nausea: While not a primary indication, some healthcare providers use CLANARIZINE DOM as adjunctive therapy for patients undergoing cancer treatment who experience both nausea and dizziness. Domperidone's strong antiemetic properties are particularly valuable in this context.Key Benefits of CLANARIZINE DOMThe unique combination of Cinnarizine and Domperidone in CLANARIZINE DOM offers numerous advantages that make it a preferred choice for managing vestibular disorders and associated symptoms.Comprehensive Symptom Control: The primary benefit of CLANARIZINE DOM is its ability to address multiple symptoms simultaneously. Rather than requiring patients to take separate medications for vertigo and nausea, this combination provides unified treatment in a single tablet. This comprehensive approach improves symptom control across the full spectrum of vestibular disorder manifestations, from the spinning sensation to the gastrointestinal distress that often accompanies it.Improved Patient Compliance: Taking multiple medications can be burdensome, particularly for patients who feel dizzy or nauseated. CLANARIZINE DOM simplifies the treatment regimen by combining two medications in one tablet, making it easier for patients to adhere to their prescribed therapy. Better compliance translates to better outcomes, as consistent medication use is essential for managing chronic vestibular conditions.Synergistic Therapeutic Effects: The combination of Cinnarizine and Domperidone creates synergistic effects that enhance overall efficacy. While Cinnarizine reduces vestibular stimulation and improves inner ear blood flow, Domperidone prevents nausea and promotes gastric emptying. This dual action addresses both the cause and consequences of vestibular dysfunction, providing more complete relief than either medication alone.Reduced Central Nervous System Side Effects: Because Domperidone works primarily in the peripheral nervous system rather than crossing the blood-brain barrier extensively, CLANARIZINE DOM causes less sedation and fewer cognitive effects compared to some alternative antiemetic medications. This allows patients to maintain better alertness and function during treatment, which is particularly important for those who need to continue working or performing daily activities.Enhanced Quality of Life: Vertigo and chronic dizziness significantly impair quality of life, limiting mobility, social interactions, and occupational functioning. The nausea and vomiting that accompany these conditions add another layer of disability. By effectively controlling both vestibular and gastrointestinal symptoms, CLANARIZINE DOM helps restore patients' ability to engage in normal activities, improving overall life satisfaction and functional independence.Fast Onset of Action: CLANARIZINE DOM provides relatively rapid symptom relief, with many patients experiencing improvement within 30 minutes to 2 hours after taking the medication. This quick onset is particularly valuable for acute episodes of vertigo or when taking the medication prophylactically before situations that might trigger motion sickness.Suitable for Long-Term Use: For patients with chronic vestibular disorders requiring ongoing treatment, CLANARIZINE DOM is generally safe for extended use when properly monitored by a healthcare provider. The medication maintains its effectiveness over time without significant tolerance development, making it suitable for long-term symptom management.Improved Gastric Emptying: The prokinetic effects of Domperidone benefit not only nausea but also other gastrointestinal symptoms such as early satiety, bloating, and upper abdominal discomfort. Patients with vestibular disorders often develop gastroparesis or delayed gastric emptying secondary to their condition, and Domperidone addresses this issue effectively.Vascular Benefits: Cinnarizine's ability to improve blood flow to the inner ear and brain provides additional benefits beyond symptom control. Enhanced microcirculation may support healing and recovery in conditions where vascular insufficiency contributes to vestibular dysfunction.Side Effects and Safety ConsiderationsLike all medications, CLANARIZINE DOM can cause side effects, though not everyone experiences them. Understanding potential adverse effects helps patients recognize when to seek medical attention and allows healthcare providers to monitor therapy appropriately.Common Side Effects:The most frequently reported side effect of CLANARIZINE DOM is drowsiness or sedation, occurring in approximately 10-20% of patients. This effect is primarily attributable to Cinnarizine's antihistaminic properties. Patients should avoid driving or operating machinery until they know how the medication affects them. Taking the medication at bedtime can minimize daytime drowsiness for some patients.Dry mouth is another common side effect, affecting roughly 10-15% of patients. This occurs due to anticholinergic effects and can be managed by sipping water frequently, chewing sugar-free gum, or using saliva substitutes if severe. Maintaining good oral hygiene is important to prevent dental problems associated with reduced saliva production.Mild gastrointestinal symptoms, including constipation, abdominal discomfort, or changes in bowel habits, may occur. While Domperidone promotes gastric emptying, it can occasionally alter bowel motility. These effects are usually mild and resolve with continued use or dose adjustment.", "price": 55.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2271, "imageuri": "https://productimages.withfloats.com/actual/6960c8410b0da405bc908e58.png", "tileimageuri": "https://productimages.withfloats.com/tile/6960c8410b0da405bc908e58.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-09T09:19:59.281Z", "updatedon": "2026-03-12T09:24:10.244Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinnarizine-and-domperidone-tablets-/2271", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CLANARIZINE DOM", "category": "NEUROLOGY RANGE", "tags": [ "cinnarizine and domperidone tablet uses", "what is cinnarizine & domperidone tablet used for", "cinnarizine domperidone combination medicine benefits", "how cinnarizine domperidone tablet works", "cinnarizine domperidone tablet for vertigo treatment", "cinnarizine domperidone tablet for inner ear problem", "cinnarizine domperidone tablet for balance disorder", "cinnarizine domperidone tablet for travel sickness", "cinnarizine domperidone tablet for gastric nausea", "cinnarizine & domperidone tablet price in india", "cinnarizine domperidone tablet brand name", "cinnarizine domperidone tablet manufacturer in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694d14f6274fc8b97e9b7120", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mirtazapine 30mg", "description": "MIRTAZPRIME 30 is a pharmaceutical formulation containing Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards. This prescription medication belongs to a class of drugs known as tetracyclic antidepressants and represents an advanced therapeutic option for individuals struggling with major depressive disorder and related mental health conditions. Manufactured under stringent quality control measures, MIRTAZPRIME 30 offers patients a reliable and effective solution for managing depression while also addressing associated symptoms such as insomnia and anxiety.\nMirtazapine, the active pharmaceutical ingredient in MIRTAZPRIME 30, works through a unique dual mechanism that distinguishes it from other antidepressants. Unlike selective serotonin reuptake inhibitors (SSRIs), mirtazapine enhances the release of both norepinephrine and serotonin in the brain by blocking specific receptors. This innovative approach not only helps alleviate depressive symptoms but also provides sedative effects that can be particularly beneficial for patients experiencing sleep disturbances alongside depression.\nTherapeutic Uses and Applications\nMIRTAZPRIME 30 is primarily indicated for the treatment of major depressive disorder (MDD), a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities. The medication has demonstrated significant efficacy in clinical trials, showing improvement in mood, energy levels, and overall quality of life for patients suffering from depression.\nBeyond its primary indication, healthcare providers may prescribe MIRTAZPRIME 30 for various off-label uses based on clinical judgment and patient needs. The medication has shown promise in managing generalized anxiety disorder, where excessive worry and tension interfere with daily functioning. Its sedative properties make it particularly valuable for patients experiencing insomnia related to depression or anxiety, as it can help restore healthy sleep patterns without the need for additional sleep medications.\nThe 30mg dosage strength represents a therapeutic level commonly prescribed for maintenance treatment after initial dose titration. Patients typically begin with lower doses and gradually increase to 30mg as their body adjusts to the medication and their symptoms require more robust management. This dosage provides an optimal balance between therapeutic efficacy and side effect management for many individuals.\nMIRTAZPRIME 30 may also be considered for patients who have not responded adequately to other antidepressant therapies, offering an alternative mechanism of action that can break through treatment-resistant depression. Additionally, its appetite-stimulating effects can be beneficial for patients experiencing significant weight loss due to depression or other medical conditions.\nKey Benefits and Therapeutic Advantages\nThe benefits of MIRTAZPRIME 30 extend beyond simple symptom relief, offering patients a multifaceted approach to mental health recovery. One of the most significant advantages is its relatively rapid onset of action compared to many other antidepressants. While most SSRIs require several weeks to demonstrate meaningful clinical improvement, patients taking mirtazapine often experience some relief from symptoms within one to two weeks, with continued improvement over subsequent weeks.\nThe dual neurotransmitter action of MIRTAZPRIME 30 provides comprehensive coverage of depressive symptoms. By enhancing both serotonergic and noradrenergic neurotransmission, the medication addresses the complex neurochemical imbalances underlying depression more thoroughly than single-mechanism antidepressants. This broader action can result in more complete symptom resolution and better overall outcomes.\nSleep improvement represents another crucial benefit of MIRTAZPRIME 30. The medication's sedative properties, particularly pronounced at lower doses, help patients fall asleep faster and enjoy more restorative sleep throughout the night. This is especially valuable since sleep disturbances are both a symptom and an exacerbating factor in depression. Better sleep quality contributes to improved daytime functioning, energy levels, and emotional regulation.\nUnlike many antidepressants that commonly cause sexual dysfunction, MIRTAZPRIME 30 has a relatively favorable profile in this regard. The medication is less likely to interfere with sexual function, making it an attractive option for patients who have experienced these troublesome side effects with other antidepressants. This characteristic can significantly improve treatment adherence and quality of life.\nThe appetite-stimulating effect, while considered a side effect by some, can be therapeutically beneficial for patients experiencing significant weight loss or poor appetite due to depression. MIRTAZPRIME 30 can help restore healthy eating patterns and reverse the physical decline that often accompanies severe depressive episodes.\nFurthermore, MIRTAZPRIME 30 does not typically cause the gastrointestinal side effects commonly associated with SSRI antidepressants, such as nausea, diarrhea, or stomach upset. This improved gastrointestinal tolerability enhances patient comfort and compliance with treatment regimens.\nPotential Side Effects and Safety Considerations\nWhile MIRTAZPRIME 30 offers numerous therapeutic benefits, patients should be aware of potential side effects that may occur during treatment. Understanding these effects helps patients make informed decisions and enables early identification of any concerning symptoms requiring medical attention.\nThe most commonly reported side effect is drowsiness or sedation, particularly during the initial weeks of treatment. This effect is typically most pronounced during the first few hours after taking the medication, which is why it's generally recommended for evening administration. Patients should exercise caution when driving, operating machinery, or engaging in activities requiring alertness until they understand how the medication affects them personally.\nIncreased appetite and weight gain represent another frequent side effect of MIRTAZPRIME 30. While beneficial for some patients, others may find this effect undesirable. Weight gain typically ranges from moderate to significant and appears to be dose-related. Patients concerned about weight should discuss dietary strategies and exercise plans with their healthcare provider.\nDry mouth is a common anticholinergic side effect that can cause discomfort but is generally manageable through increased fluid intake, sugar-free gum or candy, and good oral hygiene practices. Some patients may also experience dizziness, particularly when standing up quickly, due to the medication's effects on blood pressure regulation.\nConstipation may occur in some patients and can usually be managed through dietary modifications, increased fiber intake, adequate hydration, and regular physical activity. Less commonly, patients might experience confusion, abnormal dreams, or changes in thinking, particularly in older adults who may be more sensitive to the medication's effects.\nSerious side effects, while rare, require immediate medical attention. These include signs of allergic reactions such as rash, itching, swelling, severe dizziness, or difficulty breathing. Agranulocytosis, a dangerous decrease in white blood cells, is an extremely rare but serious complication that manifests as fever, sore throat, or signs of infection. Any unexplained fever or signs of infection should prompt immediate contact with a healthcare provider.\nSerotonin syndrome is another rare but potentially life-threatening condition that can occur when mirtazapine is combined with other medications affecting serotonin levels. Symptoms include agitation, hallucinations, rapid heartbeat, fever, excessive sweating, muscle stiffness, or coordination problems. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid dangerous interactions.\nAbrupt discontinuation of MIRTAZPRIME 30 can lead to withdrawal symptoms, including nausea, anxiety, irritability, and flu-like symptoms. Therefore, any decision to stop the medication should be made in consultation with a healthcare provider who can develop an appropriate tapering schedule.\nImportant Usage Guidelines\nMIRTAZPRIME 30 should always be taken exactly as prescribed by a qualified healthcare professional. The medication is typically administered once daily, preferably in the evening before bedtime due to its sedative effects. Tablets should be swallowed whole with water and can be taken with or without food, though taking them with food may help reduce any stomach upset.\nConsistency in timing is important for maintaining stable blood levels of the medication and optimizing therapeutic effects. Patients should try to take their dose at approximately the same time each evening. If a dose is missed, it should be taken as soon as remembered unless it's close to the time for the next scheduled dose, in which case the missed dose should be skipped rather than doubling up.\nThe full therapeutic benefits of MIRTAZPRIME 30 may take several weeks to manifest. Patients should continue taking the medication as prescribed even if they don't feel immediate improvement. Premature discontinuation is a common reason for treatment failure in depression management.\nRegular follow-up appointments with the prescribing physician are essential for monitoring treatment response, adjusting dosages if necessary, and screening for potential side effects. Patients should maintain open communication with their healthcare team about their symptoms, concerns, and any changes in their condition.\nConclusion\nMIRTAZPRIME 30 represents a valuable therapeutic option in the comprehensive management of major depressive disorder and related conditions. Its unique mechanism of action, combining enhanced noradrenergic and serotonergic neurotransmission with sedative and appetite-stimulating properties, offers distinct advantages for carefully selected patients. The medication's ability to improve both mood symptoms and sleep disturbances makes it particularly useful for patients experiencing depression accompanied by insomnia.\nThe relatively favorable side effect profile, particularly regarding sexual function and gastrointestinal tolerability, enhances patient acceptance and adherence to treatment. While potential side effects such as sedation, increased appetite, and weight gain require monitoring and management, many patients find these effects tolerable compared to the debilitating symptoms of untreated depression.\nSuccess with MIRTAZPRIME 30, as with any antidepressant therapy, depends on proper patient selection, appropriate dosing, regular monitoring, and a comprehensive treatment approach that may include psychotherapy, lifestyle modifications, and social support alongside pharmacological intervention. Patients should work closely with their healthcare providers to optimize treatment outcomes and maintain long-term mental health wellness.\nThe decision to use MIRTAZPRIME 30 should always be made collaboratively between patient and physician, considering individual symptoms, treatment history, coexisting medical conditions, and personal preferences. With proper use under medical supervision, MIRTAZPRIME 30 can be an effective tool in helping patients reclaim their lives from the devastating effects of depression and move toward recovery and renewed well-being.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2254, "imageuri": "https://productimages.withfloats.com/actual/694d14f83d39ca31a28d046b.png", "tileimageuri": "https://productimages.withfloats.com/tile/694d14f83d39ca31a28d046b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T10:41:58.966Z", "updatedon": "2026-03-13T07:46:51.004Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mirtazapine-30mg/2254", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRTAZPRIME 30", "category": "NEUROLOGYRANGE", "tags": [ "MIRTAZPRIME 30", "Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards", "managing depression", "insomnia and anxiety.", "depression or anxiety.", "depredepressive episodes.", "helping patients reclaim their lives from the devastating effects of depression." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694cf85408591c1173b54c2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pregabalin Epalrestat and Methylcobalamin Tablets", "description": "EPSTATE ED represents an advanced pharmaceutical formulation that combines three powerful therapeutic agents: Pregabalin, Epalrestat, and Methylcobalamin. This innovative triple-combination medication is specifically designed to address the complex pathophysiology of diabetic neuropathy and neuropathic pain conditions. By integrating multiple mechanisms of action, EPSTATE ED offers a comprehensive approach to managing nerve-related complications that significantly impact the quality of life for millions of individuals worldwide.\nThe formulation addresses not only the symptomatic relief of neuropathic pain but also targets the underlying metabolic derangements that contribute to nerve damage progression. This multi-pronged therapeutic strategy makes EPSTATE ED particularly valuable for patients who require more than symptomatic management alone.\nUnderstanding the Active Components\nPregabalin: The Neuropathic Pain Modulator\nPregabalin serves as the cornerstone analgesic component in EPSTATE ED. This anticonvulsant medication works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Through this mechanism, Pregabalin reduces the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. This reduction in neurotransmitter release effectively dampens the abnormal neural signaling that characterizes neuropathic pain conditions.\nThe molecule demonstrates excellent bioavailability and rapid absorption, allowing patients to experience relief within a relatively short timeframe. Its efficacy in managing various neuropathic pain syndromes has been extensively documented in clinical trials, establishing it as a first-line agent for diabetic peripheral neuropathy, postherpetic neuralgia, and other chronic neuropathic pain conditions.\nEpalrestat: The Aldose Reductase Inhibitor\nEpalrestat represents a unique addition to the formulation, functioning as a selective aldose reductase inhibitor. In diabetic conditions, excess glucose is converted to sorbitol through the polyol pathway, with aldose reductase serving as the rate-limiting enzyme. The accumulation of sorbitol within nerve cells leads to osmotic stress, depletion of myoinositol, and subsequent nerve dysfunction.\nBy inhibiting aldose reductase, Epalrestat prevents this harmful sorbitol accumulation, thereby addressing one of the fundamental metabolic abnormalities responsible for diabetic neuropathy. This disease-modifying approach distinguishes EPSTATE ED from purely symptomatic treatments. Epalrestat has been particularly well-studied in Asian populations and has demonstrated the ability to improve nerve conduction velocities and reduce subjective neuropathic symptoms over time.\nMethylcobalamin: The Neurotropic Vitamin\nMethylcobalamin, the bioactive form of Vitamin B12, completes the therapeutic triad in EPSTATE ED. Unlike cyanocobalamin, which requires conversion in the body, methylcobalamin is immediately available for utilization in crucial biochemical processes. It plays an indispensable role in myelin synthesis, the protective sheath surrounding nerve fibers that enables proper signal transmission.\nThis coenzyme participates in methionine synthesis and is essential for maintaining the structural and functional integrity of neurons. Methylcobalamin also facilitates nerve regeneration and has demonstrated neuroprotective properties in various experimental models. For patients with diabetic neuropathy, who often exhibit Vitamin B12 deficiency (sometimes exacerbated by metformin therapy), supplementation with methylcobalamin addresses both nutritional deficits and supports nerve health at a fundamental level.\nClinical Applications and Uses\nEPSTATE ED is primarily indicated for the comprehensive management of diabetic peripheral neuropathy, a condition affecting approximately 50% of individuals with long-standing diabetes. The symptoms of this condition range from tingling sensations and burning pain to numbness and loss of protective sensation, which can lead to serious complications including foot ulcers and amputations.\nBeyond diabetic neuropathy, EPSTATE ED may be prescribed for various neuropathic pain syndromes where the combination of pain relief, metabolic correction, and nerve support proves beneficial. Patients experiencing chronic nerve pain resulting from metabolic disturbances, nutritional deficiencies, or structural nerve damage may find this combination particularly effective.\nThe medication is typically recommended for adults who have not achieved adequate symptom control with single-agent therapy or who would benefit from the synergistic effects of the three components. Healthcare providers may prescribe EPSTATE ED when a patient requires both immediate symptom relief and long-term disease modification.\nKey Benefits and Therapeutic Advantages\nComprehensive Multi-Mechanism Action\nThe primary advantage of EPSTATE ED lies in its multi-faceted approach to neuropathic conditions. Rather than addressing only pain symptoms, the formulation simultaneously tackles pain perception, underlying metabolic abnormalities, and nutritional support for nerve health. This comprehensive strategy may lead to superior outcomes compared to monotherapy approaches.\nEnhanced Pain Relief\nClinical evidence supporting Pregabalin's efficacy in neuropathic pain is substantial. Patients often report significant reductions in pain intensity, improved sleep quality due to decreased nocturnal pain, and enhanced ability to perform daily activities. The pain-relieving effects typically manifest within the first week of therapy and continue to improve with ongoing treatment.\nDisease Modification Potential\nUnlike purely symptomatic treatments, the inclusion of Epalrestat provides genuine disease-modifying potential. By targeting the polyol pathway, EPSTATE ED may slow the progression of nerve damage in diabetic patients. Long-term use may preserve nerve function and prevent the worsening of neuropathic symptoms, offering hope beyond mere symptom management.\nImproved Nerve Conduction and Function\nThe combination of metabolic correction through Epalrestat and neurotropic support via Methylcobalamin creates an environment conducive to nerve regeneration and functional improvement. Studies have demonstrated improvements in nerve conduction velocity parameters with similar combination therapies, suggesting potential restoration of nerve function rather than simple symptom masking.\nConvenience of Combination Therapy\nFor patients who would otherwise require multiple separate medications, EPSTATE ED offers the convenience of a single tablet containing all three therapeutic agents. This simplification of medication regimens improves compliance, reduces pill burden, and may enhance overall treatment outcomes.\nQuality of Life Enhancement\nThe cumulative effect of pain reduction, improved nerve function, and better metabolic control translates into meaningful quality of life improvements. Patients report better mobility, reduced interference of pain with daily activities, improved mood, and enhanced social functioning.\nPotential Side Effects and Safety Considerations\nCommon Side Effects\nAs with any pharmaceutical agent, EPSTATE ED may produce certain adverse effects. The most commonly reported side effects are primarily attributable to the Pregabalin component and include dizziness, somnolence, peripheral edema, dry mouth, blurred vision, weight gain, and difficulty with concentration or attention. These effects are generally mild to moderate and often diminish with continued therapy as the body adapts to the medication.\nGastrointestinal symptoms such as constipation or nausea may occur, though they are typically manageable with dietary modifications or symptomatic treatment. Some patients experience increased appetite leading to weight gain, which requires monitoring, particularly in diabetic individuals where weight management is crucial.\nSerious but Rare Adverse Events\nThough uncommon, certain serious adverse effects warrant immediate medical attention. These include allergic reactions manifesting as rash, itching, swelling, severe dizziness, or breathing difficulties. Pregabalin has been associated with rare cases of angioedema, which requires prompt discontinuation and medical intervention.\nMental health changes, including mood alterations, anxiety, depression, agitation, or suicidal thoughts, have been reported with Pregabalin use, particularly in individuals with pre-existing psychiatric conditions. Patients and caregivers should remain vigilant for behavioral changes and report them immediately to healthcare providers.\nDrug Interactions and Precautions\nEPSTATE ED may interact with other central nervous system depressants, including alcohol, opioids, benzodiazepines, and antihistamines, potentially intensifying sedation and cognitive impairment. Patients should inform their healthcare provider of all medications, supplements, and substances they consume.\nIndividuals with kidney impairment require dose adjustments since Pregabalin is primarily eliminated through renal excretion. Regular monitoring of renal function may be necessary during long-term therapy.\nSpecial Population Considerations\nPregnant or breastfeeding women should use EPSTATE ED only when clearly necessary and under strict medical supervision, as the safety profile in these populations has not been fully established. Elderly patients may be more susceptible to side effects, particularly dizziness and confusion, necessitating careful dose titration and monitoring.\nPatients should be advised against abrupt discontinuation of EPSTATE ED, as sudden cessation of Pregabalin may precipitate withdrawal symptoms including insomnia, nausea, headache, anxiety, and sweating. Gradual dose reduction under medical supervision is recommended when discontinuing therapy.\nDosage and Administration Guidelines\nThe appropriate dosage of EPSTATE ED is highly individualized and should be determined by a qualified healthcare professional based on the patient's specific condition, response to therapy, and tolerance. Typically, treatment begins with a lower dose that is gradually increased to achieve optimal therapeutic benefit while minimizing adverse effects.\nPatients should take EPSTATE ED exactly as prescribed, with or without food, at consistent times each day to maintain stable blood levels. Missing doses should be addressed by taking the forgotten dose as soon as remembered, unless it's nearly time for the next scheduled dose. Double dosing to compensate for missed doses is not recommended.\nRegular follow-up appointments allow healthcare providers to assess treatment efficacy, monitor for adverse effects, and make necessary dose adjustments. Patients should maintain open communication with their medical team regarding symptom improvement, side effects, and any concerns that arise during therapy.\nPatient Counseling and Lifestyle Recommendations\nMaximizing the benefits of EPSTATE ED extends beyond simply taking the medication. Patients should be counseled on complementary lifestyle measures that support neuropathy management. Maintaining optimal glycemic control remains paramount for diabetic patients, as blood sugar management directly impacts neuropathy progression regardless of medication.\nRegular physical activity, within individual capabilities, promotes circulation, supports nerve health, and may enhance the therapeutic effects of EPSTATE ED. Daily foot examinations become critical for diabetic patients to identify potential injuries early, preventing serious complications.\nNutritional optimization, including adequate intake of B vitamins, antioxidants, and essential nutrients, supports the neurotropic effects of Methylcobalamin. Avoiding alcohol and tobacco, both of which can exacerbate neuropathy, is strongly recommended.\nPatients should be cautioned about activities requiring alertness, such as driving or operating machinery, especially during the initial treatment phase when dizziness and somnolence may be more pronounced. These effects typically improve with continued therapy, but individual responses vary.\nConclusion\nEPSTATE ED represents a thoughtfully designed pharmaceutical formulation that addresses the multifaceted nature of diabetic neuropathy and neuropathic pain through its unique combination of Pregabalin, Epalrestat, and Methylcobalamin. This triple-action approach offers patients more than symptomatic relief—it provides genuine disease modification potential, nutritional support, and comprehensive nerve health optimization.\nThe synergistic effects of these three components create a therapeutic profile that is greater than the sum of its parts. While Pregabalin efficiently manages pain symptoms and improves quality of life in the short term, Epalrestat works to address underlying metabolic derangements that drive disease progression, and Methylcobalamin provides essential neurotropic support for nerve regeneration and function.\nFor patients struggling with the debilitating effects of neuropathic pain and diabetic neuropathy, EPSTATE ED offers renewed hope for better symptom control and potentially slowed disease progression. The convenience of combination therapy in a single tablet improves adherence and simplifies complex treatment regimens.\nHowever, EPSTATE ED is not without considerations. Potential side effects, though generally manageable, require awareness and monitoring. The medication is most effective when integrated into a comprehensive management plan that includes optimal glycemic control, lifestyle modifications, and regular medical supervision.\nUltimately, EPSTATE ED should be viewed as a valuable tool in the therapeutic arsenal against neuropathic conditions, best utilized under the guidance of knowledgeable healthcare professionals who can individualize treatment to each patient's unique needs and circumstances. With proper use, monitoring, and patient education, EPSTATE ED can significantly improve outcomes and quality of life for those affected by these challenging neurological conditions.", "price": 275.0, "discountamount": 82.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2253, "imageuri": "https://productimages.withfloats.com/actual/694cf859d25fa0b0657b1ac8.png", "tileimageuri": "https://productimages.withfloats.com/tile/694cf859d25fa0b0657b1ac8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T08:39:48.947Z", "updatedon": "2026-04-18T09:21:49.885Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pregabalin-epalrestat-and-methylcobalamin-tablets/2253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EPSTATE ED", "category": "NEUROLOGYRANGE", "tags": [ "regabalin, Epalrestat, and Methylcobalamin.neuropathic pain conditions.", "Pregabalin, Epalrestat, and Methylcobalamin.", "neuropathic pain.", "diabetic neuropathy.", "sorbitol within nerve cells leads to osmotic stress.", "Epalrestat and neurotropic support via Methylcobalamin creates an environment .", "mood alterations, anxiety, depression, agitation.", "supports the neurotropic effects of Methylcobalamin.", "Pregabalin Epalrestat and Methylcobalamin Tablets", "epalrestat and methylcobalamin tablets uses", "epalrestat and methylcobalamin tablets in hindi", "pregabalin epalrestat and methylcobalamin tablets price jaipur", "pregabalin epalrestat and methylcobalamin tablets price india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c05831844c6739ab3e83a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mefenamic Acid and Paracetamol Suspension", "description": "METAPECT MF KID SUSPENSION stands out as a specialized formulation from Steris Healthcare Pvt Ltd, blending Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), with Paracetamol, a widely used analgesic and antipyretic. Typically available in a 60ml bottle with child-friendly flavoring, it contains precise concentrations like 100mg Mefenamic Acid and 250mg Paracetamol per 5ml serving, ensuring accurate dosing via the included measuring cup. This sugar-free or low-sugar variant minimizes dental risks while providing rapid absorption for faster onset compared to solid forms. Manufactured under stringent quality controls, it supports pediatric care by addressing inflammation at its source through COX enzyme inhibition, which curbs prostaglandin production responsible for pain signals and fever response.​\n\nThe suspension's dual-action mechanism sets it apart: Paracetamol targets the brain's hypothalamus to regulate body temperature and elevate pain thresholds, while Mefenamic Acid reduces tissue swelling and inflammatory mediators. This synergy makes METAPECT MF KID SUSPENSION more effective than single-ingredient options for multifaceted symptoms. Healthcare professionals often recommend it for short-term use in infants over six months and children, always under medical guidance to match age and weight-based dosages.​\n\nKey Uses\nMETAPECT MF KID SUSPENSION excels in managing fever associated with viral infections, teething, or post-vaccination reactions. It swiftly lowers elevated temperatures, promoting comfort and better sleep for restless kids.​\n\nFor pain relief, it tackles mild to moderate discomfort from headaches, toothaches, earaches, and sore throats common during colds or flu. Caregivers report noticeable easing of symptoms within 30-60 minutes, allowing children to resume play or eat without distress.​\n\nAdditionally, it soothes body aches, muscle strains from minor injuries, or joint pains in growing kids. In cases of post-surgical recovery or inflammatory episodes, it provides reliable support without the need for stronger opioids.​\n\nMajor Benefits\nThe primary benefit lies in its comprehensive symptom control, combining antipyretic, analgesic, and anti-inflammatory effects for holistic relief. Children experience reduced fever, less pain, and diminished swelling, leading to improved appetite and activity levels.​\n\nIts liquid suspension format ensures easy administration—no choking risks—and precise dosing prevents under- or overdosing. Flavored options like mango enhance compliance, turning medicine time into a less daunting routine for picky eaters.​\n\nCompared to alternatives, METAPECT MF KID SUSPENSION offers quicker bioavailability due to its oral liquid state, ideal for emergencies like high fever spikes at night. Long-term, it supports faster recovery by minimizing inflammation, potentially shortening illness duration when used as directed.​\n\nBenefit\tDescription:\tAdvantage over Single Agents\nFever Reduction\tLowers temperature via hypothalamic action ​\tFaster than Paracetamol alone\nPain Relief\tBlocks pain signals and prostaglandins. ​\tSuperior for inflammatory pain\nAnti-Inflammatory\tReduces swelling in tissues ​\tAddresses root cause, not just symptoms\nEasy Dosing\tLiquid with dropper for accuracy ​\tChild-friendly, no splitting tablets\nPotential Side Effects\nWhile generally well-tolerated, METAPECT MF KID SUSPENSION may cause mild gastrointestinal issues like nausea, vomiting, stomach pain, or indigestion in some children, especially if taken on an empty stomach. Administering with food can mitigate this.​\n\nLess common effects include drowsiness, dizziness, or allergic reactions such as rashes, itching, or swelling—seek immediate medical help if these occur. Prolonged use risks liver strain from Paracetamol or kidney concerns from Mefenamic Acid, so adhere strictly to prescribed durations.​\nRarely, it might lead to diarrhea, headache, or elevated liver enzymes. Monitoring is key; consult a doctor for persistent symptoms or in kids with pre-existing conditions like asthma or ulcers.​\n\nDosage Guidelines\nFollow pediatrician-recommended doses based on weight: typically 5-10ml every 6-8 hours, not exceeding 4 doses daily. Shake well before use and store below 30°C away from light.​\nAvoid in neonates under 6 months or those with hypersensitivity. Hydration and diet play roles in efficacy—pair with plenty of fluids.​\nConclusion\nMETAPECT MF KID SUSPENSION empowers parents with a dependable tool for childhood pain and fever, blending efficacy, safety, and convenience under Steris Healthcare's trusted banner. Quick relief restores normalcy, but professional oversight ensures optimal outcomes.", "price": 57.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2241, "imageuri": "https://productimages.withfloats.com/actual/693c05860443b6722a4db029.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c05860443b6722a4db029.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:07:31.874Z", "updatedon": "2026-03-12T07:38:26.246Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mefenamic-acid-and-paracetamol-suspension/2241", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT MF KID SUSPENSION", "category": "PEDIATRICS", "tags": [ "Mefenamic Acid and Paracetamol Suspension", "Paracetamol", "Mefenamic Acid and 250mg Paracetamol per 5ml serving", "COX enzyme inhibition", "pain and fever", "Pain Relief", "mefenamic acid.", "mefenamic acid tablet uses.", "mefenamic acid and paracetamol suspension.", "mefenamic acid suspension.", "paracetamol and mefenamic acid suspension.", "mefenamic acid and paracetamol suspension uses." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }